These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3014368)

  • 1. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants.
    Gobbi G; Melideo G; Giovanardi Rossi P
    Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma).
    Boltshauser E; Deonna T; Hirt HR
    Helv Paediatr Acta; 1979 May; 34(2):119-33. PubMed ID: 222713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
    Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J
    Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 8. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.
    Magnussen I; Mondrup K; Engbaek F; Lademann A; Olivarius BD
    Acta Neurol Scand; 1982 Aug; 66(2):276-82. PubMed ID: 6215817
    [No Abstract]   [Full Text] [Related]  

  • 10. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

  • 12. Myoclonic encephalopathy of infants.
    Lott I; Kinsbourne M
    Adv Neurol; 1986; 43():127-36. PubMed ID: 3004125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 14. L-5 HTP available under treatment IND.
    FDA Drug Bull; 1983 Aug; 13(2):12-3. PubMed ID: 6604672
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin and myoclonic seizures.
    Munsat TL
    N Engl J Med; 1977 Jan; 296(2):101-2. PubMed ID: 299730
    [No Abstract]   [Full Text] [Related]  

  • 16. Myoclonic encephalopathy. ("Dancing eyes" syndrome with myoclonic ataxia).
    Gross-Selbeck G; Goll U
    Klin Padiatr; 1972 Sep; 184(5):393-9. PubMed ID: 4343942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myoclonic encephalopathy (Kinsbourne syndrome)].
    Kaulfersch W; Urban C; Fritsch G; Maurer G
    Padiatr Padol; 1984; 19(3):279-85. PubMed ID: 6472868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
    Avanzini G; Bossi L; Caraceni T; Consolazione A; Franceschetti S; Negri S; Parati E
    Monogr Neural Sci; 1980; 5():142-52. PubMed ID: 6976509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.